1. Home
  2. PZZA vs TECX Comparison

PZZA vs TECX Comparison

Compare PZZA & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

N/A

Current Price

$19.70

Market Cap

640.7M

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$23.33

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PZZA
TECX
Founded
1984
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
640.7M
618.9M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
PZZA
TECX
Price
$19.70
$23.33
Analyst Decision
Hold
Strong Buy
Analyst Count
13
9
Target Price
$29.00
★ $76.63
AVG Volume (30 Days)
★ 1.4M
233.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 7.09%
N/A
EPS Growth
N/A
★ 40.70
EPS
★ 0.46
N/A
Revenue
★ $2,068,421,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.30
★ N/A
Revenue Growth
★ 14.07
N/A
52 Week Low
$18.92
$15.45
52 Week High
$55.74
$39.53

Technical Indicators

Market Signals
Indicator
PZZA
TECX
Relative Strength Index (RSI) 35.92 33.51
Support Level $19.31 $20.52
Resistance Level $24.25 $30.80
Average True Range (ATR) 0.62 1.39
MACD 0.18 0.11
Stochastic Oscillator 32.88 27.11

Price Performance

Historical Comparison
PZZA
TECX

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: